‘Pharmaceutical manufacturers that claim patent rights over multiple compounds on the basis of a general formula will welcome a new ruling by the Court of Appeal in London, experts in patent litigation have said.’
OUT-LAW.com, 2nd September 2021
Source: www.pinsentmasons.com
